The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial assessing oral S-1 combined with fixed doses of irinotecan in advanced gastrointestinal malignancies (aGM) in 1st- or 2nd-line treatment.
 
Emmanuelle Samalin
Consulting or Advisory Role - Amgen; Roche; Sanofi
Research Funding - Merck (Inst); Nordic Bioscience (Inst)
Travel, Accommodations, Expenses - BMS Brazil; Ipsen; Roche
 
Antoine Italiano
No Relationships to Disclose
 
Simon Thezenas
No Relationships to Disclose
 
Thibault Mazard
Honoraria - Bayer; Sanofi
Research Funding - Amgen (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen
 
Eric Assenat
Honoraria - Bayer; Novartis; Sirtex Medical
Consulting or Advisory Role - Ipsen; Sanofi
Travel, Accommodations, Expenses - Bayer; Ipsen
 
Sophie Cousin
No Relationships to Disclose
 
Antoine Adenis
Honoraria - Bristol-Myers Squibb; SERVIER
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Sanofi; SERVIER
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Novartis; Sanofi
Research Funding - Bayer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Merck; Merck Serono; Sanofi
 
Sylvain Poujol
No Relationships to Disclose
 
Isabelle Solassol
No Relationships to Disclose
 
Patrick Chalbos
No Relationships to Disclose
 
Fabienne Portales
Honoraria - Sanofi
Travel, Accommodations, Expenses - Roche
 
Marc Ychou
Consulting or Advisory Role - Amgen; Bayer; Roche; SERVIER